Written answer
Vaccination Programme
907. Deputy Cormac Devlin asked the Minister for Health the cohorts that will qualify for the State-funded shingles vaccination programme when it commences; the estimated number of persons in each cohort; the anticipated start date for vaccination of immunocompromised persons aged 65 years and older; the proposed timetable for extending the programme to all persons aged 65 years and older. [79235/26]
Comment on this
908. Deputy Cormac Devlin asked the Minister for Health to provide an update including a timeline on when the shingles vaccine programme is expected to be rolled out to those eligible, over 65 and immunocompromised. [79233/26]
Comment on this
914. Deputy Darren O'Rourke asked the Minister for Health if the shingles vaccination programme for persons aged over 65 years-of-age will be free of charge with effect from January 2027 from GPs and pharmacies. [79381/26]
Comment on this
I propose to take Questions Nos. 907, 908 and 914 together.
Ireland’s immunisation programme is informed by the advice of the National Immunisation Advisory Committee (NIAC). NIAC considers the prevalence of the relevant disease in Ireland as well as international best practice in relation to immunisation when developing its advice.
The current NIAC guidelines state that the shingles vaccine may be considered for those aged 65 years and older, due to the greater burden and severity of disease in this age group and in those aged 18 years and older at increased risk of shingles.
I can confirm that I have approved the introduction of a Shingles Vaccination Programme, in line with NIAC advice, to be implemented on a phased basis over 5 years, for immuno-compromised groups and persons aged 65 and over.
The programme is expected to commence in 2027, initially offering shingles vaccines to immuno-compromised groups. This will be followed by the 80 years and older cohort. The programme will conclude with the 65–69-year-old cohort.
It is expected that the vaccine will be administered in the main by GPs and Pharmacists. Further programme details will become available in due course.